Daniel Friedman, MD

Assistant Professor of Medicine
Campus mail 2301 Erwin Road, Suite 7451, Durham, NC 27701
Phone (919) 681-6020
Email address daniel.friedman@duke.edu

My research areas of interest include improving the safety and efficacy of complex ablation and optimal use of pacemakers in patients with heart failure, including cardiac resynchronization therapy and conduction system pacing. I am also interested in non-pharmacologic management of atrial fibrillation, including catheter ablation and left atrial appendage occlusion, and understanding optimal use of novel and emerging technologies.

Education and Training

  • Board Certified, Clinical Cardiac Electrophysiology, American Board of Internal Medicine, 2020 - 2030
  • Fellowship, Clinical Cardiac Electrophysiology, Duke University School of Medicine, 2017 - 2019
  • Board Certified, Cardiovascular Diseases, American Board of Internal Medicine, 2016 - 2026
  • Board Certified, Internal Medicine, American Board of Internal Medicine, 2013 - 2023
  • Fellowship, Cardiovascular Diseases, Duke University School of Medicine, 2013 - 2017
  • Residency, Internal Medicine, Massachusetts General Hospital, 2011 - 2013
  • M.D., Cornell University, Weill Medical College, 2010
  • B.S., Cornell University, 2006
  • C., High School, 2002

Publications

Emerek, Kasper, Daniel J. Friedman, Peter Lyngø Sørensen, Steen Møller Hansen, Jacob Moesgaard Larsen, Niels Risum, Anna Margrethe Thøgersen, et al. “Vectorcardiographic QRS area is associated with long-term outcome after cardiac resynchronization therapy.” Heart Rhythm 16, no. 2 (February 2019): 213–19. https://doi.org/10.1016/j.hrthm.2018.08.028.

PMID
30170227
Full Text

Friedman, Daniel J., and Sana M. Al-Khatib. “Response by Friedman and Al-Khatib to Letter Regarding Article, "Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry".” Circulation 138, no. 25 (December 18, 2018): 2972–73. https://doi.org/10.1161/CIRCULATIONAHA.118.037098.

PMID
30566023
Full Text

Ambrosy, Andrew P., Craig S. Parzynski, Daniel J. Friedman, Marat Fudim, Adrian F. Hernandez, Gregg C. Fonarow, Frederick A. Masoudi, and Sana M. Al-Khatib. “Is Time From Last Hospitalization for Heart Failure to Placement of a Primary Prevention Implantable Cardioverter-Defibrillator Associated With Patient Outcomes?” Circulation 138, no. 24 (December 11, 2018): 2787–97. https://doi.org/10.1161/CIRCULATIONAHA.118.035627.

PMID
30565983
Full Text

Friedman, Daniel J., Peter Liu, Adam S. Barnett, Kristen Bova Campbell, Kevin P. Jackson, Tristram D. Bahnson, James P. Daubert, and Jonathan P. Piccini. “Obstructive sleep apnea is associated with increased rotor burden in patients undergoing focal impulse and rotor modification guided atrial fibrillation ablation.” Europace 20, no. FI_3 (November 1, 2018): f337–42. https://doi.org/10.1093/europace/eux248.

PMID
29016785
Full Text

Friedman, Daniel J., and Brett D. Atwater. “Peeling back of left bundle branch refractoriness facilitates mapping of a hemodynamically unstable atrial flutter.” J Cardiovasc Electrophysiol 29, no. 9 (September 2018): 1319–20. https://doi.org/10.1111/jce.13617.

PMID
29697172
Full Text

Friedman, Daniel J., Kasper Emerek, Peter Søgaard, Maryam Vejdani-Jahromi, Joseph Kisslo, and Brett D. Atwater. “The mechanical and hemodynamic effects of left ventricular pacing in heart failure with preserved ejection fraction and left bundle branch block.” J Electrocardiol 51, no. 5 (September 2018): 859–62. https://doi.org/10.1016/j.jelectrocard.2018.07.004.

PMID
30177329
Full Text

Friedman, Daniel J., and Christopher B. Granger. “Uninterrupted apixaban for atrial fibrillation ablation is a reasonable alternative, but what is the significance of silent cerebral infarctions?” Eur Heart J 39, no. 32 (August 21, 2018): 2956–58. https://doi.org/10.1093/eurheartj/ehy274.

PMID
29788351
Full Text

Pages